Advertisement

Related Videos

David A. Hyman, MD, JD, on Inclusive Shared Savings

Cody Peer, PhD, on Simulating Alternative Schedules for Checkpoint Inhibitors

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on Alternative Dispensing Strategies

CS Pramesh, MS, FRCS, on Opportunities in India: A Perspective From a Low-Middle Income Country

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

Advertisement

Advertisement




Feb
06
Today In Oncology
ASH 2025: Highlights in Relapsed/Refractory Multiple Myeloma
Chemotherapy-Free Regimen Improves Outcomes in Newly Diagnosed Patients With Ph-Positive ALL
Early Results Show Pirtobrutinib Matches Ibrutinib in BTK Inhibitor-Naive CLL
Colorectal Cancer Liver Metastases: Transplant or Resect?
Metastasis-Directed Therapy for Oligometastatic Prostate Cancer
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo